These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34545958)

  • 41. An attempt to use the serum concentration of the phosphate (Pi) and the Ca x P product as markers of the progression of chronic kidney disease in cats.
    Sławuta P; Kumiega E; Sikorska-Kopyłowicz A; Sapikowski G; Kurosad A
    Pol J Vet Sci; 2019 Dec; 22(4):647-652. PubMed ID: 31867923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fortified phosphorus‑lowering treatment through administration of lanthanum protects against vascular calcification via regulation of FGF23 in chronic kidney disease.
    Jiang J; Li Y; Zheng D; Wang Z; Zhou H; Liu G
    Int J Mol Med; 2020 Nov; 46(5):1783-1793. PubMed ID: 32901861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of calcifediol supplementation on markers of chronic kidney disease-mineral and bone disorder in dogs with chronic kidney disease.
    Parker VJ; Rudinsky AJ; Benedict JA; Beizaei A; Chew DJ
    J Vet Intern Med; 2020 Nov; 34(6):2497-2506. PubMed ID: 33128421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.
    Isakova T; Barchi-Chung A; Enfield G; Smith K; Vargas G; Houston J; Xie H; Wahl P; Schiavenato E; Dosch A; Gutiérrez OM; Diego J; Lenz O; Contreras G; Mendez A; Weiner RB; Wolf M
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):1009-18. PubMed ID: 23471131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammation both increases and causes resistance to FGF23 in normal and uremic rats.
    Rodríguez-Ortiz ME; Díaz-Tocados JM; Muñoz-Castañeda JR; Herencia C; Pineda C; Martínez-Moreno JM; Montes de Oca A; López-Baltanás R; Alcalá-Díaz J; Ortiz A; Aguilera-Tejero E; Felsenfeld A; Rodríguez M; Almadén Y
    Clin Sci (Lond); 2020 Jan; 134(1):15-32. PubMed ID: 31860056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cats with IRIS stage 1 and 2 chronic kidney disease maintain body weight and lean muscle mass when fed food having increased caloric density, and enhanced concentrations of carnitine and essential amino acids.
    Hall JA; Fritsch DA; Jewell DE; Burris PA; Gross KL
    Vet Rec; 2019 Feb; 184(6):190. PubMed ID: 30514741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary magnesium supplementation in cats with chronic kidney disease: A prospective double-blind randomized controlled trial.
    Tang PK; van den Broek DHN; Jepson RE; Geddes RF; Chang YM; Lötter N; Moniot D; Biourge V; Elliott J
    J Vet Intern Med; 2024 Jul; ():. PubMed ID: 38952053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment options for hyperphosphatemia in feline CKD: what's out there?
    Kidder AC; Chew D
    J Feline Med Surg; 2009 Nov; 11(11):913-24. PubMed ID: 19857854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upper urolithiasis in cats with chronic kidney disease: prevalence and investigation of serum and urinary calcium concentrations.
    Hsu HH; Ueno S; Miyakawa H; Ogawa M; Miyagawa Y; Takemura N
    J Feline Med Surg; 2022 Jun; 24(6):e70-e75. PubMed ID: 35471088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats.
    Ross SJ; Osborne CA; Kirk CA; Lowry SR; Koehler LA; Polzin DJ
    J Am Vet Med Assoc; 2006 Sep; 229(6):949-57. PubMed ID: 16978113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of phosphorus, calcium, and magnesium content in commercially available foods formulated for healthy cats.
    Summers SC; Stockman J; Larsen JA; Zhang L; Rodriguez AS
    J Vet Intern Med; 2020 Jan; 34(1):266-273. PubMed ID: 31883277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of lower versus higher phosphate diets on fibroblast growth factor-23 levels in patients with chronic kidney disease: a systematic review and meta-analysis.
    Tsai WC; Wu HY; Peng YS; Hsu SP; Chiu YL; Chen HY; Yang JY; Ko MJ; Pai MF; Tu YK; Hung KY; Chien KL
    Nephrol Dial Transplant; 2018 Nov; 33(11):1977-1983. PubMed ID: 29420827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.
    Stubbs JR; He N; Idiculla A; Gillihan R; Liu S; David V; Hong Y; Quarles LD
    J Bone Miner Res; 2012 Jan; 27(1):38-46. PubMed ID: 22031097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.
    Isakova T; Gutiérrez OM; Smith K; Epstein M; Keating LK; Jüppner H; Wolf M
    Nephrol Dial Transplant; 2011 Feb; 26(2):584-91. PubMed ID: 20631407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survey of dietary and medication practices of owners of cats with chronic kidney disease.
    Markovich JE; Freeman LM; Labato MA; Heinze CR
    J Feline Med Surg; 2015 Dec; 17(12):979-83. PubMed ID: 25535212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate.
    Summers S; Quimby JM; Phillips RK; Stockman J; Isaiah A; Lidbury JA; Steiner JM; Suchodolski J
    J Vet Intern Med; 2020 Jan; 34(1):206-215. PubMed ID: 31693251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary active transforming growth factor β in feline chronic kidney disease.
    Lawson JS; Syme HM; Wheeler-Jones CP; Elliott J
    Vet J; 2016 Aug; 214():1-6. PubMed ID: 27387717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease.
    van den Broek DHN; Geddes RF; Williams TL; Chang YM; Elliott J; Jepson RE
    J Vet Intern Med; 2018 Mar; 32(2):727-735. PubMed ID: 29469976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal Study to Find the Association of Serum Phosphorus Level with FGF23 in Three Different Hyperphosphatemia Management Groups of Stage 3 and 4 Chronic Kidney Disease (CKD) Patients.
    Mahapatra HS; Kaur N; Sharma N; Pursnani L; Kumar M; Inamdar N; Singh M; Arora T
    Indian J Nephrol; 2022; 32(6):574-581. PubMed ID: 36704588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.